Kenvue Inc. (KVUE) Stock-Based Compensation
The stock-based comp for Kenvue Inc. (KVUE) is $136.00 Million with a year-over-year change of -46.46%. Stock-Based Compensation (SBC) is the expense recognized for equity awards (stock options, RSUs) granted to employees. It's a non-cash expense that dilutes existing shareholders.
KVUE Stock-Based Comp Chart
Reported annual fiscal-period values; no daily interpolation.
Current Stock-Based Comp
$136.00M
$136.00 Million
Year-over-Year Change
-46.46%
vs. $254.00M prior year
Historical Data
7
Years of data available
Annual Stock-Based Comp History
| Year | Stock-Based Comp | YoY Change | % Change |
|---|---|---|---|
| 2025 | $136.00M | $-118.00M | -46.46% |
| 2024 | $254.00M | +$66.00M | +35.11% |
| 2023 | $188.00M | +$51.00M | +37.23% |
| 2022 | $137.00M | $-4.00M | -2.84% |
| 2021 | $141.00M | +$26.00M | +22.61% |
| 2020 | $115.00M | +$13.00M | +12.75% |
| 2019 | $102.00M | — | — |
Related Metrics
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry